Early diagnosis of depressive symptoms as part of the comprehensive management of breast cancer patients

doi:10.5306/wjco.v16.i8.106627

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=9

Aug 24, 2025 (publication date) through Aug 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Aug 24, 2025; 16(8): 106627
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.106627

Early diagnosis of depressive symptoms as part of the comprehensive management of breast cancer patients

Macarena Teja, Abrahams Ocanto, Felipe Couñago

Macarena Teja, Abrahams Ocanto, Felipe Couñago, Department of Radiation Oncology, Genesis Care-San Francisco de Asís University Hospital, Madrid 28002, Spain

Macarena Teja, Abrahams Ocanto, Felipe Couñago, Department of Radiation Oncology, Genesis Care-Vithas La Milagrosa University Hospital, Madrid 28010, Spain

Felipe Couñago, Department of Radiation Oncology, National Director, GenesisCare-Spain, Madrid 28010, Spain

Felipe Couñago, Department of Medicine, Faculty of Medicine, Health and Sport Sciences, Universidad Europea de Madrid, Madrid 28011, Spain

Author contributions: Teja M contributed to the review of the literature, the discussion and design of the manuscript; Teja M, Ocanto A and Couñago F contributed to writing and editing the manuscript; All authors contributed to this paper.

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Macarena Teja, MD, Department of Radiation Oncology, Genesis Care-San Francisco de Asís University Hospital, C/Joaquín Costa 28, Madrid 28002, Spain. macarena.teja@genesiscare.es

Received: March 3, 2025
Revised: April 11, 2025
Accepted: May 8, 2025
Published online: August 24, 2025
Processing time: 170 Days and 11.9 Hours

Core Tip

Core Tip: Breast cancer is the most common cancer in women and depressive symptoms are frequent during the disease. A recent study by Mao et al developed a nomogram predictive model for depression in young and middle-aged breast cancer patients. The results showed strong predictive capability with high sensitivity and specificity. However, the geographical limitations of the sample and the cross-sectional design of the study limit the conclusions. Besides, there is a need of developing and standardizing screening tests and tools to assess risk factors for depression in breast cancer patients in the context of a comprehensive management.